Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every funding round, exec hire, M&A move, contract, and sentiment shift on Tolemy Bio — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

Tolemy Bio secures €1.4M in pre-seed funding to enhance its AI-driven cell biology research technology, led by Norrsken Evolve.

PRIVATEMay 12, 2026•7 days ago

Amount Raised

€1.4 Million

Round Type

seed

Cambridge

Investors

A New Uk Based Stealth FundMasiaJme VenturesBig Sur VenturesNorrsken Evolve

Description

Cambridge-based Tolemy Bio has raised €1.4 million in pre-seed funding to advance its AI-enabled technology for cell biology research. The funding will be used to expand data generation and machine learning capabilities, as well as support early customer deployments. The round was led by Norrsken Evolve with participation from multiple investors. Tolemy Bio aims to optimize the fragmented workflows in biopharma and cell biology using its platform, Orbit.

Company Information

Company

Tolemy Bio

Location

Cambridge, England, United Kingdom

About

Tolemy Bio is a biotech startup that focuses on AI-enabled technology for cell biology research and biopharma development. The company is developing Orbit, a system designed to help researchers better understand and optimize living cells used in modern therapies. Tolemy Bio aims to streamline experimental workflows, which are currently fragmented and manual, to enhance the application of AI tools in drug development. The company's ultimate goal is to create a virtual-cell platform that facilitates more precise and data-driven experimentation in biopharma.

Predictive Intelligence
Strategic

ML-powered predictions for Tolemy Bio's next move

Learn about Strategic plan

Related People

Suggested for you
2 contacts

Sign in to view contact details

Sign in to view contact details

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, FundzIQ™ for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies.

Watching Tolemy Bio? See every signal — funding, hires, M&A, contracts, sentiment.

See plans